Barclays cut target for Intuitive Surgical stock to USD 485.00

Published on 10/12/2026 at 11:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue reached USD 2.89 billion, up 18.40 percent year over year. Intuitive Surgical stock stood at EUR 379.40 on October 12, 2026 before the October 20 report.

Key points in brief

Barclays cut its Intuitive Surgical price target from USD 651.00 to USD 485.00 on October 7, 2026.
Second-quarter 2026 revenue reached USD 2.89 billion, up 18.40 percent year over year.
Intuitive Surgical stock was trading at EUR 379.40 at Lang & Schwarz on October 12, 2026 at 11:22 a.m. CEST.
The company scheduled its third-quarter 2026 earnings conference for October 20, 2026.

Overhead-Flatlay von laparoskopischen Trokaren und artikulierten Endeffektor-Instrumenten mit Metallfinish in geometrischer Anordnung auf weißem Hintergrund, weiches Studiolicho von oben — Intuitive Surgical US46120E6023 Flatlay zeigt chirurgische Roboterinstrumente und Trokar Komponenten auf weißem Untergrund, Illustration mit AI erstellt.

Barclays cut its Intuitive Surgical stock target from USD 651.00 to USD 485.00 on October 7, 2026, according to Moomoo News. The change puts analyst valuation directly against the companys latest operating figures and the next earnings date.

Three events shape the setup

On July 16, 2026, Intuitive Surgical reported second-quarter revenue of USD 2.89 billion, up 18.40 percent from the same period a year earlier. Zacks said adjusted earnings per share reached USD 2.80 and exceeded consensus by 12.90 percent.

On September 8, 2026, Intuitive highlighted a meta-analysis covering 13 common benign conditions in its investor news section. The companys October 7 analyst update then moved the valuation discussion to USD 485.00, the most recent quantified event in this sequence.

What does the target cut change?

The Barclays action matters because the new USD 485.00 target is USD 166.00 below the previous USD 651.00 target, a 25.50 percent reduction calculated from the old target. The report retained a buy rating, according to Moomoo News.

That valuation reset arrives before the next operating checkpoint. Intuitive Surgical lists its third-quarter 2026 earnings conference for October 20, 2026, at 1:30 p.m. PDT on its investor-relations page.

Revenue growth meets a lower target

The second-quarter revenue comparison remains the clearest operating figure: USD 2.89 billion versus USD 2.44 billion in the prior-year quarter. The USD 450.00 million increase corresponds to the reported 18.40 percent growth rate, while adjusted earnings per share of USD 2.80 exceeded the USD 2.48 consensus estimate.

For investors, the October report will provide the next dated test of procedure growth, system placements and margins. Those metrics connect the companys 18.40 percent revenue expansion with the lower analyst valuation, rather than treating the target change as an operating result.

Stock price before October earnings

Intuitive Surgical was trading at EUR 379.40 at Lang & Schwarz on October 12, 2026, at 11:22 a.m. CEST. The quote is an intraday euro reference for German-market readers ahead of the scheduled October 20 earnings conference.

The further course of trading is shown by the continuously updated real-time quote of Intuitive Surgical stock.